title: Role of NK2 receptors in gastric barosensitivity and in experimental ileus in rats.
abstract: This study was performed to evaluate the role of tachykinin NK2 receptors in gastric barosensitivity and in postsurgical intestinal atony, using a selective NK2 antagonist (MEN 11420). Gastric distensions were performed in rats equipped with a gastric balloon and electrodes implanted in the neck muscles. Ileus was produced by laparotomy and caecum palpation in rats previously prepared with electrodes implanted on the proximal jejunum. Fifteen minutes before gastric distension or laparotomy, the animals received MEN 11420 (10, 100 or 200 microg kg-1 intravenously) or saline. The first distending pressure to increase the integrated neck electromyogram > 100% was considered the pain threshold. MEN 11420 (100 microg kg-1) increased significantly pain threshold (20.5 +/- 1.2 vs. 17.0 +/- 0.8 mm Hg) but did not modify gastric volumes at the three doses tested. Abdominal surgery was followed by a total inhibition of jejunal spiking activity lasting 80.4 +/- 18.7 min. MEN 11420 (10 and 100 microg kg-1) shortened the duration of motor inhibition by 36 and 39%, and induced a premature recovery of the phase III of migrating myoelectric complex at the lowest dose tested (130 +/- 32 vs. 192 +/- 28 min). We conclude that NK2 receptors, probably located on afferent fibres, are involved in gastric barosensitivity and in postsurgical intestinal atony.
authors.affiliation: Department of Pharmacology INRA, France.
authors.forename: M
authors.initials: M
authors.lastname: Toulouse
authors.forename: J
authors.initials: J
authors.lastname: Fioramonti
authors.forename: C
authors.initials: C
authors.lastname: Maggi
authors.forename: L
authors.initials: L
authors.lastname: Buéno
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000399:Air Pressure; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D004576:Electromyography; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007415:Intestinal Obstruction / Q000503:physiopathology* / Q000523:psychology; D007583:Jejunum / Q000187:drug effects / Q000502:physiology; D008297:Male; D010146:Pain / Q000503:physiopathology; D010456:Peptides, Cyclic / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018041:Receptors, Neurokinin-2 / Q000037:antagonists & inhibitors / Q000502:physiology*; D013270:Stomach / Q000187:drug effects / Q000503:physiopathology*; D015016:Yohimbine / Q000494:pharmacology
chemical_list: D000317:Adrenergic alpha-Antagonists; C107754:MEN 11420; D010456:Peptides, Cyclic; D018041:Receptors, Neurokinin-2; D015016:Yohimbine